Latest news
AuctuCel launches AuctuPrime to reduce biological variability in cell therapy manufacturing - Macau BusinessMacau Business · Tue, 04 Aug 2026 07:00:00 GMTRepligen: Acquisition To Add Cell Therapy Capabilities (NASDAQ:RGEN) - Seeking AlphaSeeking Alpha · Sun, 02 Aug 2026 15:50:56 GMTRepligen to Acquire BioLife Solutions, Enhancing Cell Therapy Capabilities - SynBioBetaSynBioBeta · Tue, 28 Jul 2026 07:00:00 GMT